anti-mesothelin CAR vector-transduced T lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-010884
A preparation of genetically modified T lymphocytes transduced with a lentiviral vector encoding a chimeric antigen receptor (CAR) specific for the human tumor-associated antigen (TAA) mesothelin (MSLN), with potential immunomodulating and antineoplastic activities. Upon administration, the anti-MSLN CAR vector-transduced T-lymphocytes specifically target and kill MSLN-expressing tumor cells. MSLN, a cell surface glycoprotein involved in cell adhesion, is overexpressed in a variety of cancer cell types.
| Identifier | MLC-T-ONC-010884 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-MSLN CAR-T cells; HuCART-meso |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010884",
"term": "anti-mesothelin CAR vector-transduced T lymphocytes",
"field": "Oncology and biomedicine",
"definition": "A preparation of genetically modified T lymphocytes transduced with a lentiviral vector encoding a chimeric antigen receptor (CAR) specific for the human tumor-associated antigen (TAA) mesothelin (MSLN), with potential immunomodulating and antineoplastic activities. Upon administration, the anti-MSLN CAR vector-transduced T-lymphocytes specifically target and kill MSLN-expressing tumor cells. MSLN, a cell surface glycoprotein involved in cell adhesion, is overexpressed in a variety of cancer cell types.",
"synonyms": [
"anti-MSLN CAR-T cells",
"HuCART-meso"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-mesothelin-car-vector-transduced-t-lymphocytes/"
}
Record 2,002 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.